Icosavax Inc.

NASDAQ: ICVX · Real-Time Price · USD
15.31
-0.14 (-0.91%)
At close: Feb 16, 2024, 10:00 PM

Icosavax Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-91.76M -66.97M
Depreciation & Amortization
860K 82K
Stock-Based Compensation
21.69M 29.03M
Other Working Capital
9.27M -3.74M
Other Non-Cash Items
-545K 264K
Deferred Income Tax
n/a 959K
Change in Working Capital
8.07M -1.91M
Operating Cash Flow
-61.67M -38.54M
Capital Expenditures
-11.11M -1.01M
Cash Acquisitions
158.34M n/a
Purchase of Investments
-221.09M n/a
Sales Maturities Of Investments
62.75M n/a
Other Investing Acitivies
-158.34M n/a
Investing Cash Flow
-169.45M -1.01M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
10.31M 304.77M
Financial Cash Flow
10.31M 304.77M
Net Cash Flow
-220.82M 265.23M
Free Cash Flow
-72.79M -39.55M